European Urology Open Science (Jul 2020)

Short term health-related quality-of-life in men with metastatic castration-resistant prostate cancer treated with first-line enzalutamide or abiraterone plus prednisone: A systematic review and meta-analysis

  • K. Ternov Kvorning,
  • A.B. Nolsøe,
  • O. Bratt,
  • M. Fode,
  • H. Lindberg,
  • C. Kistorp,
  • G. Palapattu,
  • T.W. Klausen,
  • J. Sønksen,
  • P.B. Østergren

Journal volume & issue
Vol. 19
pp. e869 – e870

Abstract

Read online

No abstracts available.